Amarin’s John Thero Awarded EY Entrepreneur of The Year® 2019 Life Sciences National AwardGlobeNewsWire • 11/18/19
This Biotech Stock Is Fishing For A Breakout On A Key RecommendationInvestors Business Daily • 11/15/19
Amarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of Vascepa® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-IT® Outcomes TrialGlobeNewsWire • 11/14/19
Will A Positive FDA Committee Vote Send This Biotech Into A Breakout?Investors Business Daily • 11/14/19
Amarin Corporation plc (NASDAQ:AMRN) Stock Trading Halted Today for Scheduled FDA Advisory Committee Review of sNDA Seeking New Indication for Vascepa® (Icosapent Ethyl) to Reduce the Risk of Major Adverse Cardiovascular Events Based on Landmark REDUCE-IGlobeNewsWire • 11/14/19
This Biotech Just Gapped Up As FDA Mulls A Second Use For Its MedicineInvestors Business Daily • 11/12/19